Hepatitis
From the Journals
Liver disease and death rates fall after hepatitis C treatment barriers are dismantled
Uptake is uneven, and more needs to be done to facilitate treatment.
From the Journals
Bulevirtide reduces hepatitis D viral load in difficult-to-treat patients
Bulevirtide led to a significant viral response in 78% of patients by week 48.
Conference Coverage
Finding HBV ‘cure’ may mean going ‘back to the drawing board’
Development of new HBV drugs looks more complicated than initially expected, and it’s time to refine and refocus goals, according to one...
Conference Coverage
Phase 3 data shows bulevirtide benefit in hepatitis D
“For us in the hepatitis D field, it is a really exciting time; it’s completely novel data and game-changing for patients.”
Latest News
Acute hepatitis cases in children show declining trend; adenovirus, COVID-19 remain key leads
Adenovirus remains the most commonly detected virus in acute hepatitis in children, found in 53% of cases overall.
Latest News
CDC releases new details on mysterious hepatitis in children
The findings suggest that there may be many different causes behind these severe hepatitis cases, the authors wrote, and it is estimated that...
Latest News
Pediatric hepatitis has not increased during pandemic: CDC
Neither pediatric hepatitis nor adenovirus type 40/41 are reportable conditions in the United States.
Opinion
Is hepatitis C an STI?
Which sexually transmitted infection tests should this patient receive?
From the Journals
TDF use in HBV-HIV coinfection linked with kidney, bone issues
News from the FDA/CDC
CDC updates guidelines for hepatitis outbreak among children
WHO officials expect data within a week from U.K. cases, which may indicate whether the adenovirus is an incidental infection or a more direct...
Feature
DOJ complaint flags HCV drug denials for people with addiction
Alabama Medicaid has an illegal policy of denying HCV treatment to people who have used illegal drugs or alcohol, according to the complaint.